Nordea Investment Management
BIO icon

Nordea Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Nordea Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,067
Closed -$489K – 867
2025
Q1 		$489K Buy
2,067
+6
+0.3% +$1.8K ﹤0.01% 860
2024
Q4 		$679K Hold
2,061
– – ﹤0.01% 852
2024
Q3 		$684K Sell
2,061
-3,958
-66% -$1.26M ﹤0.01% 860
2024
Q2 		$1.65M Sell
6,019
-291
-5% -$84.6K ﹤0.01% 725
2024
Q1 		$2.18M Sell
6,310
-479
-7% -$158K ﹤0.01% 694
2023
Q4 		$2.21M Sell
6,789
-3,368
-33% -$1.06M ﹤0.01% 689
2023
Q3 		$3.65M Buy
10,157
+579
+6% +$223K 0.01% 574
2023
Q2 		$3.64M Buy
9,578
+7,689
+407% +$3.13M 0.01% 584
2023
Q1 		$897K Sell
1,889
-96
-5% -$44.9K ﹤0.01% 809
2022
Q4 		$828K Buy
1,985
+480
+32% +$194K ﹤0.01% 807
2022
Q3 		$633K Buy
1,505
+75
+5% +$37.4K ﹤0.01% 861
2022
Q2 		$702K Buy
1,430
+279
+24% +$145K ﹤0.01% 856
2022
Q1 		$662K Hold
1,151
– – ﹤0.01% 863
2021
Q4 		$866K Hold
1,151
– – ﹤0.01% 832
2021
Q3 		$875K Hold
1,151
– – ﹤0.01% 832
2021
Q2 		$742K Sell
1,151
-68
-6% -$41.4K ﹤0.01% 856
2021
Q1 		$695K Hold
1,219
– – ﹤0.01% 843
2020
Q4 		$711K Buy
1,219
+5
+0.4% +$2.85K ﹤0.01% 807
2020
Q3 		$630K Sell
1,214
-1,086
-47% -$550K ﹤0.01% 780
2020
Q2 		$1.01M Buy
2,300
+1,318
+134% +$582K ﹤0.01% 796
2020
Q1 		$342K Hold
982
– – ﹤0.01% 853
2019
Q4 		$364K Buy
+982
New +$346K ﹤0.01% 897

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Nordea Investment Management's BIO Position: Q2 2025 in Review

Nordea Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 2,067 shares — an estimated $489K sold.

Nordea Investment Management first reported a position in BIO in Q4 2019 and held it in 22 quarters. The position peaked at $3.65M in Q3 2023. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Nordea Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Nordea Investment Management sold 2,067 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $489K.
  • Nordea Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 22 quarters.
  • Nordea Investment Management's Bio-Rad Laboratories Class A position peaked at $3.65M in Q3 2023.
  • 383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Nordea Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.